News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
489,814 Results
Type
Article (8021)
Company Profile (150)
Press Release (481643)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166741)
Career Advice (304)
Deals (25739)
Drug Delivery (7)
Drug Development (52880)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238196)
Policy (17898)
Tag
2025 Best Places to Work (5)
2026 Best Places to Work (12)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (502)
Accelerated approval (31)
ADA (18)
Adcomms (1)
Allergies (103)
Alliances (33156)
ALS (123)
Alzheimer's disease (1021)
Antibody-drug conjugate (ADC) (338)
Approvals (10498)
Artificial intelligence (385)
ASCO (160)
Autoimmune disease (261)
Automation (34)
Bankruptcy (264)
Belgium (4)
Best Places to Work (6957)
BIO (36)
Biologics (65)
BIOSECURE Act (1)
Biosimilars (127)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (31)
Bladder cancer (150)
Brain cancer (37)
Breast cancer (555)
Cancer (4151)
Cardiovascular disease (249)
Career advice (245)
Career pathing (1)
CAR-T (196)
CDC (2)
CDMO (36)
Celiac Disease (3)
Cell therapy (538)
Cervical cancer (37)
Clinical research (48651)
Collaboration (1388)
Commercialization (35)
Compensation (1669)
Complete response letters (37)
COVID-19 (779)
CRISPR (75)
C-suite (873)
Cystic fibrosis (89)
Data (6762)
Denatured (4)
Depression (109)
Dermatology (106)
Diabetes (392)
Diagnostics (4288)
Digital health (44)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (178)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (176)
Earnings (74566)
Editorial (1)
Employer branding (2)
Employer resources (14)
ESMO (240)
Events (89279)
Executive appointments (745)
Eye disease (8)
FDA (12749)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (21)
Frontotemporal dementia (26)
Funding (1012)
Gene editing (140)
Generative AI (15)
Gene therapy (359)
GLP-1 (323)
Government (953)
Grass and pollen (2)
Guidances (288)
Healthcare (9451)
Hematology (115)
HIV (60)
Huntington's disease (30)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (82)
Immunology and inflammation (115)
Immuno-oncology (75)
Indications (190)
Infectious disease (989)
Inflammatory bowel disease (145)
Inflation Reduction Act (4)
Influenza (90)
Intellectual property (277)
Interviews (41)
IPO (12401)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (93)
Layoffs (59)
Legal (5195)
Licensing (71)
Liver cancer (47)
Longevity (28)
Lung cancer (590)
Lung diease (11)
Lymphoma (282)
Machine learning (30)
Management (3)
Manufacturing (632)
Marketing (25)
MASH (131)
Medical affairs (2)
Medical device (8730)
Medtech (8933)
Mergers & acquisitions (14497)
Metabolic disorders (802)
mRNA (83)
Multiple sclerosis (118)
Multispecific (3)
NASH (4)
Netherlands (4)
Neurodegenerative disease (250)
Neuropsychiatric disorders (41)
Neuroscience (1997)
Neurotech (2)
NextGen: Class of 2026 (3151)
Non-profit (845)
Obesity (251)
Opinion (10)
Ovarian cancer (185)
Pain (195)
Pancreatic cancer (240)
Parkinson's disease (221)
Partnered (12)
Patents (535)
Patient advocacy (3)
Patient recruitment (550)
Patient selection (55)
Peanut (34)
People (41578)
Peptides (26)
Pharmaceutical (30)
Pharmacy benefit managers (11)
Phase 1 (15710)
Phase 2 (21760)
Phase 3 (14678)
Pipeline (9134)
Policy (20)
Postmarket research (1570)
Preclinical (6626)
Press Release (34)
Prostate cancer (212)
Psychedelics (13)
Radiopharmaceuticals (205)
Rare diseases (642)
Real estate (3025)
Recruiting (6)
Regenerative medicine (18)
Regulatory (15270)
Reports (27)
Research institute (596)
Resumes & cover letters (45)
Rett syndrome (48)
RNA editing (9)
RSV (52)
Schizophrenia (112)
Series A (179)
Series B (129)
Service/supplier (5)
Sickle cell disease (70)
Spinal muscular atrophy (93)
Sponsored (5)
Startups (2022)
Stem cells (3)
Stomach cancer (3)
Substance use disorders (17)
Supply chain (57)
Switzerland (2)
Tariffs (2)
Vaccines (362)
Venture capital (18)
Weight loss (83)
Wet AMD (3)
Women's health (102)
Date
Today (132)
Last 7 days (590)
Last 30 days (2415)
Last 365 days (19215)
2026 (17446)
2025 (19252)
2024 (22987)
2023 (26540)
2022 (34587)
2021 (37167)
2020 (33470)
2019 (23256)
2018 (17469)
2017 (18764)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (233)
Alabama (81)
Alaska (2)
Arizona (332)
Arkansas (12)
Asia (18109)
Australia (2129)
California (13433)
Canada (3465)
China (596)
Colorado (553)
Connecticut (472)
Delaware (237)
Europe (24867)
Florida (1999)
Georgia (423)
Hawaii (3)
Idaho (46)
Illinois (803)
India (66)
Indiana (340)
Iowa (19)
Japan (471)
Kansas (106)
Kentucky (34)
Louisiana (30)
Maine (27)
Maryland (1320)
Massachusetts (8790)
Michigan (326)
Minnesota (623)
Mississippi (5)
Missouri (86)
Montana (20)
Nebraska (11)
Nevada (142)
New Hampshire (61)
New Jersey (2958)
New Mexico (12)
New York (3131)
North Carolina (1417)
North Dakota (4)
Northern California (6824)
Ohio (311)
Oklahoma (15)
Oregon (17)
Pennsylvania (2499)
Puerto Rico (24)
Rhode Island (32)
South America (407)
South Carolina (82)
South Dakota (1)
Southern California (5622)
Tennessee (133)
Texas (2222)
United States (43429)
Utah (406)
Vermont (1)
Virginia (169)
Washington D.C. (39)
Washington State (1023)
West Virginia (1)
Wisconsin (84)
Wyoming (1)
489,814 Results for "genprex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genprex to Highlight Dual Delivery Strategy for Diabetes Gene Therapy at Future of Cell and Gene Therapy Symposium
November 11, 2026
·
6 min read
Press Releases
Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer
November 4, 2026
·
8 min read
Press Releases
Andelyn Biosciences to Scale Manufacturing for Genprex’s Diabetes Gene Therapy Program
September 1, 2026
·
5 min read
Press Releases
Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026
·
5 min read
Press Releases
Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
October 28, 2026
·
7 min read
Press Releases
Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging
October 21, 2026
·
7 min read
Press Releases
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies
August 3, 2026
·
7 min read
Press Releases
Genprex to Participate at BIO International Convention 2026
June 17, 2026
·
5 min read
Press Releases
Genprex Presents Data Showing Reqorsa® Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Patients, Supporting TUSC2 as a Key Regulator of Resilience to Aging-Associated Stress
November 5, 2026
·
8 min read
Press Releases
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy
August 18, 2026
·
8 min read
1 of 48,982
Next